Anti-inflammatory cytokines such as Interleukin-10 (Il-10) reduce inflammation during AD pathogenesis with increased levels in the central and peripheral nervous systems indicating disease severity with rapid cognitive decline (Strle et al., 2001; Leung et al., 2013; Park et al., 2020). This evidence concerns the gene IL10 and Alzheimer disease.